GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xenon Pharmaceuticals Inc (FRA:XP0) » Definitions » E10

Xenon Pharmaceuticals (FRA:XP0) E10 : €-1.91 (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Xenon Pharmaceuticals E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Xenon Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2024 was €-0.802. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-1.91 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-14), Xenon Pharmaceuticals's current stock price is €31.60. Xenon Pharmaceuticals's E10 for the quarter that ended in Dec. 2024 was €-1.91. Xenon Pharmaceuticals's Shiller PE Ratio of today is .


Xenon Pharmaceuticals E10 Historical Data

The historical data trend for Xenon Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xenon Pharmaceuticals E10 Chart

Xenon Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -1.18 -1.50 -1.91

Xenon Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.50 -1.55 -1.56 -1.62 -1.91

Competitive Comparison of Xenon Pharmaceuticals's E10

For the Biotechnology subindustry, Xenon Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xenon Pharmaceuticals's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xenon Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Xenon Pharmaceuticals's Shiller PE Ratio falls into.



Xenon Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Xenon Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.802/127.3637*127.3637
=-0.802

Current CPI (Dec. 2024) = 127.3637.

Xenon Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201503 -0.591 99.789 -0.754
201506 -0.062 100.500 -0.079
201509 -0.241 100.421 -0.306
201512 -0.248 99.947 -0.316
201603 -0.207 101.054 -0.261
201606 -0.374 102.002 -0.467
201609 -0.454 101.765 -0.568
201612 -0.303 101.449 -0.380
201703 -0.402 102.634 -0.499
201706 -0.365 103.029 -0.451
201709 -0.361 103.345 -0.445
201712 -0.380 103.345 -0.468
201803 -0.170 105.004 -0.206
201806 -0.385 105.557 -0.465
201809 -0.540 105.636 -0.651
201812 -0.255 105.399 -0.308
201903 -0.372 106.979 -0.443
201906 -0.327 107.690 -0.387
201909 -0.300 107.611 -0.355
201912 -0.369 107.769 -0.436
202003 -0.199 107.927 -0.235
202006 -0.004 108.401 -0.005
202009 -0.212 108.164 -0.250
202012 -0.279 108.559 -0.327
202103 -0.353 110.298 -0.408
202106 -0.423 111.720 -0.482
202109 -0.306 112.905 -0.345
202112 -0.425 113.774 -0.476
202203 -0.318 117.646 -0.344
202206 -0.520 120.806 -0.548
202209 -0.576 120.648 -0.608
202212 -0.538 120.964 -0.566
202303 -0.588 122.702 -0.610
202306 -0.665 124.203 -0.682
202309 -0.684 125.230 -0.696
202312 -0.587 125.072 -0.598
202403 -0.570 126.258 -0.575
202406 -0.697 127.522 -0.696
202409 -0.730 127.285 -0.730
202412 -0.802 127.364 -0.802

Add all the adjusted EPS together and divide 10 will get our e10.


Xenon Pharmaceuticals  (FRA:XP0) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Xenon Pharmaceuticals E10 Related Terms

Thank you for viewing the detailed overview of Xenon Pharmaceuticals's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Xenon Pharmaceuticals Business Description

Traded in Other Exchanges
Address
200-3650 Gilmore Way, Burnaby, BC, CAN, V5G 4W8
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

Xenon Pharmaceuticals Headlines

No Headlines